Liu, Y., Zhang, Y., Gao, J., Wang, L., Xie, F., Zhang, C., . . . Yan, J. (2025). Venetoclax and hypomethylating agents versus induction chemotherapy for newly diagnosed acute myeloid leukemia patients. BMC Cancer, 25(1), 1. https://doi.org/10.1186/s12885-025-14311-9
Chicago-referens (17:e uppl.)Liu, Yun, Ying Zhang, Jinhong Gao, Lijuan Wang, Fang Xie, Chengtao Zhang, Peimin Mao, och Jinsong Yan. "Venetoclax and Hypomethylating Agents Versus Induction Chemotherapy for Newly Diagnosed Acute Myeloid Leukemia Patients." BMC Cancer 25, no. 1 (2025): 1. https://doi.org/10.1186/s12885-025-14311-9.
MLA-referens (9:e uppl.)Liu, Yun, et al. "Venetoclax and Hypomethylating Agents Versus Induction Chemotherapy for Newly Diagnosed Acute Myeloid Leukemia Patients." BMC Cancer, vol. 25, no. 1, 2025, p. 1, https://doi.org/10.1186/s12885-025-14311-9.
